Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial. - Perrot A; Touzeau C; Lambert J; Hulin C; Caillot D; Karlin L; Arnulf B; Rey P; Garderet L; Macro M; Escoffre Barbe M; Gay J; et al. (Blood, 2025)